<DOC>
<DOCNO>
EP-0000276
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/423 C07D-263/57 A61K-9/20 C07D-263/00 <main>C07D-263/56</main> A61K-31/42 A61P-29/00 C07D-263/56 
</IPC-CLASSIFICATIONS>
<TITLE>
a novel crystalline form of benoxaprofen, methods of preparation thereof and pharmaceutical formulations containing said novel form.
</TITLE>
<APPLICANT>
lilly industries ltdgb  <sep>lilly industries limited<sep>lilly industries limitedhenrietta house henrietta placelondon w1m 0edgb<sep>lilly industries limited<sep>
</APPLICANT>
<INVENTOR>
hicks terence alan<sep>sherlock roy<sep>hicks, terence alan<sep>sherlock, roy<sep>hicks, terence alanrydal close covefarnborough hampshiregb<sep>sherlock, roy"downs end" 113, wodeland avenueguildford surreygb<sep>hicks, terence alan  <sep>sherlock, roy<sep>hicks, terence alanrydal close covefarnborough hampshiregb<sep>sherlock, roy"downs end" 113, wodeland avenueguildford surreygb<sep>
</INVENTOR>
<ABSTRACT>
a novel crystalling form of benoxaprofen, methods of  preparation thereof and pharmaceutical formulations containing  said novel form.  a thermodynamically stable polymorph of benoxaprofen,  an antiinflammatory agent of the structural formula:  this stable polymorphic form, which can be prepared  from the mastastable form by thermal treatment or crystallisation  from a solution, is used in pharmaceutical formulations.  
</ABSTRACT>
</TEXT>
</DOC>
